FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

10625411000001108: Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36250601000001113 Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70045101000001116 Kaletra 200mg/50mg tablets (AbbVie Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Is a Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has active ingredient Ritonavir false Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has active ingredient Lopinavir false Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Is a Kaletra true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has specific active ingredient Ritonavir true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has specific active ingredient Lopinavir true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Has AMP True Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) 120 tablet Is pack of False Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) 120 tablet Has AMP True Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start